GPR39 agonist TC-G 1008 promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. 2019

Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
School of Medicine, Shandong University , Ji'nan , China.

Osteoporosis-related bone fracture and falls have a severe impact on patients' daily lives. Osteoblasts are bone-building cells that play a vital role in bone formation and remodeling. Imbalanced osteoblast differentiation could lead to osteoporosis. GPR39 is an orphan G protein-coupled receptor that mediates metabolic pathways. In this study, we show that GPR39 is expressed in MC3T3-E1 cells. Osteoblast differentiation culture media induces GPR39, suggesting that GPR39 is a differentiation-responsive factor. Activation of GPR39 using its selective agonist TC-G 1008 induces alkaline phosphatase (ALP), osteocalcin (OCN), and type I collagen (Col-I) expression, and increases cellular ALP activity and calcium deposition, implying that GPR activation promotes cells toward osteoblast differentiation. Treatment with TC-G 1008 also increases Runx-2 expression and AMPK activation. However, the inhibition of AMPK by Compound C abolished TC-G 1008-mediated ALP, OCN, and Col-I induction, and reduces ALP activity and cellular calcium deposition as well as Runx-2 induction. These data indicate that TC-G 1008-mediated GPR39 activation involves AMPK-mediated Runx-2 induction. In summary, our study uncovers a new role of GPR39 activation in osteoblast differentiation, implying that GPR39 could be a promising therapeutic target for osteoporosis.

UI MeSH Term Description Entries
D008903 Minerals Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Mineral
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D010012 Osteogenesis The process of bone formation. Histogenesis of bone including ossification. Bone Formation,Ossification, Physiologic,Endochondral Ossification,Ossification,Ossification, Physiological,Osteoclastogenesis,Physiologic Ossification,Endochondral Ossifications,Ossification, Endochondral,Ossifications,Ossifications, Endochondral,Osteoclastogeneses,Physiological Ossification
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
January 2001, Biochemical and biophysical research communications,
Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
December 2019, Artificial cells, nanomedicine, and biotechnology,
Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
April 2006, Matrix biology : journal of the International Society for Matrix Biology,
Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
January 2021, Evidence-based complementary and alternative medicine : eCAM,
Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
April 2005, Bone,
Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
February 2019, Journal of affective disorders,
Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
September 2016, Journal of affective disorders,
Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
May 2019, Molecular medicine reports,
Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
November 2020, Aging,
Xingyu Chai, and Wencan Zhang, and Bingying Chang, and Xianli Feng, and Jiang Song, and Le Li, and Chenxiao Yu, and Junyong Zhao, and Haipeng Si
November 2014, Journal of pineal research,
Copied contents to your clipboard!